科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Hepatopancreatobiliary Surgery,
Shenzhen Institute of Translational Medicine
Yong Ni has not added Biography.
If you are Yong Ni and would like to personalize this page please email our Author Liaison for assistance.
MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Hepatobiliary & pancreatic diseases international : HBPD INT Aug, 2018 | Pubmed ID: 30108016
The First affiliated hospital of Shenzhen University, Shenzhen Second People's Hospital
Ying Lu*,1,2,
Zuhui Pu*,3,
Jiao Chen2,
Jing Deng2,
Ying Deng2,4,
Shufang Zhu2,
Chunliang Xu5,
Fuwen Yao1,2,
Zijing Wu1,2,
Yong Ni1,
Yongqiang Zhan1,
Jun Cheng1,
Naiyang Zhan1,
Wenlong Huang6,
Zhiming Cai2,
Rita Bottino7,
Lisha Mou2
1Department of Hepatopancreatobiliary Surgery, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
2Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Shenzhen Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
3Imaging Department, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
4Faculty of Science, University of Waterloo,
5School of Life Science, The Chinese University of Hong Kong,
6General Surgery, The First Affiliated Hospital of Shantou University Medical College,
7Director Islet Programs, Imagine Pharma
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。